Even before the pandemic, many people experienced anxiety from the pressures of work, family, finances and world events. The pandemic has only worsened this anxiety. You may recognize the common symptoms: excessive worrying, restlessness, difficulty sleeping, trouble concentrating. Today, people are seeking relief with CBD. Here’s why.
CBD (cannabidiol) is an active cannabinoid that’s extracted from cannabis. Unlike the cannabinoid THC (tetrahydrocannabinol), CBD doesn’t cause a euphoric high. It can actually reverse excessive euphoria, paranoia and anxiety associated with ingesting higher-dose THC.
There’s been exciting research into how CBD can help with stress, anxiety and PTSD. Numerous studies have examined CBD’s anti-anxiety effects, and it has proven to be effective in reducing behavioural and physiological signs. CBD has also been shown to help with insomnia and replaying traumatic memories. While CBD in moderate doses (10 mg sublingually or orally) may be effective for anxiety, CBD combined with low-dose THC is effective in disrupting REM sleep and dreams, thereby reducing PTSD symptoms, especially nightmares.
CBD interacts with the body’s endocannabinoid system (ECS), which has important roles in controlling anxiety. Through the ECS, our bodies produce endocannabinoids. When they bind to endocannabinoid receptors attached to our cells, they send a message that the ECS needs to act. CBD behaves similarly to endocannabinoids. It may prevent endocannabinoids from breaking down or bind to certain receptors. CBD also decreases blood flow in the brain regions associated with anxiety, seems to alter serotonin signals and may reduce cortisol levels.
Evidence suggests that CBD could be a safe alternative for anxiety as it does not cause sedation. Benzodiazepines (e.g. lorazepam, alprazolam) are addictive, cause drowsiness, can’t be mixed with alcohol, can slow breathing and cause fatal overdose – which are not concerns with CBD. Similarly, CBD doesn’t have the side-effects of selective serotonin reuptake inhibitors (e.g. fluoxetine, fluvoxamine).
Oral CBD is usually poorly absorbed. Oral CBD tends not to be as effective as inhaled because only 8-10% of the CBD is absorbed into the bloodstream (vs. 50-60% when inhaled). CBD absorption can improve to 40-45% when administered with VESIsorb® oral or VersaFilm® sublingual technologies. Furthermore, most oral products contain little or no cannabidiolic acid (CBDA), which has stronger serotonin receptor activity and may play a more important role in managing anxiety in combination with CBD versus CBD alone.
Opticann’s new revolutionary CBD products have rapid-acting, superior absorption.
Opticann’s optimized cannabinoids are based on advanced pharmaceutical drug-delivery technologies.
CB4 Control sublingual strips are the first CBD- and CBDA-containing filmstrip developed with VersaFilm® for better, faster absorption into the bloodstream (less than 5 minutes) than conventional oils and capsules and can be taken as needed. Each under-the-tongue dissolving strip contains 10 mg CBD (6 mg CBD and 4 mg CBDA) and less than 0.2 mg THC.
For chronic daily relief, Opticann’s two variations of softgel products provide 25 mg of high-potency CBD made with VESIsorb®, clinically proven to deliver 4.5 times absorption 3 times faster (1 hour vs. 3 hours) than conventional capsules. CB4 Relief contains no THC and is recommended for daytime. CB4 Relief-T contains low-dose THC (0.75 mg), making it suitable for evening use before bed.
Talk to your doctor, pharmacist and Opticann’s Patient Care Team about effective medical cannabis products. They can advise you on dosage, drug interactions, precautions and contraindications. To get access, sign up as a patient.
Please enter your date of birth. You must be 19 years of age or older (18+ in Alberta, 21+ in Québec) to access this website.